{{Rsnum
|rsid=344924
|Chromosome=1
|position=67639770
|Orientation=minus
|GMAF=0.2172
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 6.2 | 93.8
| HCB | 8.0 | 48.2 | 43.8
| JPT | 15.9 | 46.9 | 37.2
| YRI | 23.1 | 59.2 | 17.7
| ASW | 14.0 | 36.8 | 49.1
| CHB | 8.0 | 48.2 | 43.8
| CHD | 6.4 | 51.4 | 42.2
| GIH | 5.9 | 22.8 | 71.3
| LWK | 10.0 | 44.5 | 45.5
| MEX | 3.4 | 22.4 | 74.1
| MKK | 8.4 | 31.2 | 60.4
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23478653
  |Trait=Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer
  |Title=A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy.
  |RiskAllele=
  |Pval=3E-7
  |OR=4.90
  |ORtxt=[2.70-9.0]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}